| January 22nd | 2020 7:59AM
Johnson & Johnson posts higher sales, big 4Q profit jump
Higher prescription drug sales helped push Johnson & Johnson's fourth-quarter profit up by 32%.
The world's biggest maker of health care products on Wednesday reported net income of $4.01 billion, or $1.50 per share. That's up from $3.04 billion, or $1.12, a year earlier.
Adjusted earnings came to $1.88 per share, matching the expectations of industry analysts, according to a survey by FactSet.